Replies to post #1134 on Generex Biotechnology Corp. (fka GNBTQ)

[rstar]

GNBT's wholly-owned immunotherapeutics subsidiary ,Antigen Expressis interested in partnering its development programs in cancer, H5 avian influenza and HIV. In addition, Antigen Express technologies are widely applicable to different immunotherapy strategies.
http://antigenexpress.com/business_development.html

Swine Flu Outbreak Unnerves Mexico City

http://www.voanews.com/english/2009-04-24-voa50.cfm